Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
Garcia-Soto AE, Java JJ, Nieves Neira W, Pearson JM, Cohn DE, Lele SB, Tewari KS, Walker JL, Alvarez Secord A, Armstrong DK, Copeland LJ. Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study. Gynecol Oncol. 2016 Dec; 143(3):484-489.
-
Adenocarcinoma, Clear Cell
-
Adenocarcinoma, Clear Cell
-
Aged
-
Aged
-
Antineoplastic Agents
-
Antineoplastic Agents
-
Carcinoma, Endometrioid
-
Carcinoma, Endometrioid
-
Chemotherapy, Adjuvant
-
Chemotherapy, Adjuvant
-
Cytoreduction Surgical Procedures
-
Cytoreduction Surgical Procedures
-
Disease-Free Survival
-
Disease-Free Survival
-
Female
-
Female
-
Humans
-
Humans
-
Infusions, Parenteral
-
Infusions, Parenteral
-
Middle Aged
-
Middle Aged
-
Neoplasm Staging
-
Neoplasm Staging
-
Neoplasm, Residual
-
Neoplasm, Residual
-
Neoplasms, Cystic, Mucinous, and Serous
-
Neoplasms, Cystic, Mucinous, and Serous
-
Neoplasms, Glandular and Epithelial
-
Neoplasms, Glandular and Epithelial
-
Ovarian Neoplasms
-
Ovarian Neoplasms
-
Paclitaxel
-
Paclitaxel
-
Prognosis
-
Prognosis
-
Proportional Hazards Models
-
Proportional Hazards Models
-
Retrospective Studies
-
Retrospective Studies
-
Survival Rate
-
Survival Rate
-
Time Factors
-
Time Factors